Oracle’s $125 Billion Debt Question Looms Over a Record $553 Billion Backlog

When Oracle reports its fiscal fourth-quarter results on June 16, the market will be looking for more than just another earnings beat. The company is carrying a staggering $124.7 billion in long-term debt, its free cash flow is deeply negative at roughly $25 billion, and interest expenses have climbed 32% — yet its backlog of contracted but unfulfilled revenue has exploded to $553 billion. That tension between future promise and present financial strain defines the moment for the database giant.

The stock closed recently at $145.62 (€145.62), down nearly 13% year-to-date and roughly 48% below its 52-week high of $280.70. Over the past 30 days, however, shares have rebounded about 15%, driven largely by the expanded multicloud partnership with Amazon Web Services. The 200-day moving average near $184 remains a distant target.

AWS Expansion as a Litmus Test

Oracle has been rapidly scaling its multicloud footprint. The number of AWS regions it connects to has jumped from two to eight, with a target of 22 by the end of the current quarter. That would mark a tangible operational milestone for the infrastructure strategy, lowering the barrier for enterprise customers running workloads across multiple cloud environments. The stock surged roughly 25% in a single week after the AWS deal was announced, underscoring how much is riding on execution.

Beyond AWS, Oracle now operates 33 Microsoft Azure regions and 14 Google Cloud regions. The breadth of these partnerships is central to the bull case: if Oracle can embed its database and AI services across all major clouds, the addressable market expands dramatically.

A $30 Billion Fundraising Blitz

In the midst of this expansion, Oracle pulled off an extraordinary financing maneuver. The company had outlined plans to raise $45 billion to $50 billion through a mix of bonds, mandatory convertible notes, and an at-the-market equity program of up to $20 billion. Within days of the announcement, it had already collected $30 billion, with the order book significantly oversubscribed, according to the company.

Wedbush analyst Dan Ives characterized the move as a strategic effort to strengthen the balance sheet and secure resources for contractual commitments already on the books. The rapid execution suggests strong institutional confidence in Oracle’s ability to convert its backlog into revenue — at least among bond buyers.

Growth Metrics That Demand Attention

The bull case rests on numbers that are hard to ignore. The remaining performance obligation (RPO) surged 325% year-over-year to $553 billion. GPU revenue jumped 177%, while multicloud database consumption soared 817%. Oracle Cloud Infrastructure (OCI) grew 84% to $4.9 billion in the fiscal third quarter. For the full year 2027, management is targeting $90 billion in total revenue.

Should investors sell immediately? Or is it worth buying Oracle?

Key customers include OpenAI, which has committed to a $30 billion annual spend, along with Meta and xAI. Oracle emphasizes that much of the infrastructure buildout is either pre-financed by customer payments or involves clients contributing GPUs directly, limiting the company’s own capital exposure.

For the fiscal fourth quarter, management expects revenue growth of 18% to 20% in constant currency (or 19% to 21% per some guidance), with non-GAAP EPS between $1.96 and $2.00. The consensus estimate sits at $1.95.

The Bear Case: Debt and Cash Flow

The counterargument is equally stark. Long-term debt of $124.7 billion weighs on the balance sheet, and capital expenditures of roughly $48 billion have pushed free cash flow deeply negative — by about $25 billion. As long as interest rates remain elevated, the financing risk is real. Bears argue that the company is essentially borrowing heavily to build infrastructure for contracts that may take years to fully materialize.

Bulls counter that the negative cash flow is the price of building capacity for AI workloads already under contract. The question is timing: when will that backlog translate into recognizable revenue and positive cash generation?

Analyst Divergence Reflects Uncertainty

Of the 46 analysts covering Oracle, 35 rate the stock a buy. The average price target is around $260 to $261, implying significant upside from current levels. But the range is unusually wide: Guggenheim sees a target of $400, while RBC Capital holds at $160. That dispersion captures the core debate — whether Oracle’s massive investments will pay off in the near term or require years of patience.

The fiscal third quarter was an outlier, with both revenue and adjusted earnings per share growing more than 20% for the first time in 15 years. The bar for Q4 is high. The June 16 report will offer the first real test of whether Oracle’s record backlog is a foundation for sustained growth — or a weight that the balance sheet can no longer carry.